Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immune checkpoint inhibitors for cancer and venous thromboembolic events

European Journal of Cancer(2021)10.1016/j.ejca.2021.09.010Source: DataRank Database

Immune checkpoint inhibitors for cancer and venous thromboembolic events is a research paper published in European Journal of Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 78 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access78 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 9.69)OA: greenTopics (16)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Zsófia D. Drobni ORCID,Raza M. Alvi,Sean Murphy ORCID,Ryan J. Sullivan ORCID,Sarah Hartmann

Live enrichment

PubMed:34662835 PMC:PMC9010482 OpenAlex:https://openalex.org/W3205623667

National Institutes of Health

Grant: P30 AI060354

National Institutes of Health

Grant: T32HL076136

National Heart, Lung, and Blood Institute

Grant: K24HL150238

National Heart, Lung, and Blood Institute

Grant: R01HL137562

National Heart, Lung, and Blood Institute

Grant: R01HL130539

Harvard University Center for AIDS Research

AstraZeneca

FWCI

9.69

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9010482

publisherhttps://api.elsevier.com/content/article/PII:S0959804921006055?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0959804921006055?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ejca.2021.09.010

Fields of Study

Venous Thromboembolism Diagnosis and ManagementCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease Prognosis

Keywords

MedicineImmune systemCancerImmune checkpointOncologyInternal medicineImmunologyImmunotherapyAnticoagulationVenous ThromboembolismVascular MedicineCardio-oncologyImmune Checkpoint Inhibitors

Sustainable Development Goals

SDG 0: Good health and well-being